5 Intriguing Things Illumina's Management Said in Its Q3 Update
"Let the good times roll" might be a good theme for Illumina (NASDAQ: ILMN) in 2017. The gene-sequencing pioneer reported its third-quarter results on Tuesday. Illumina once again beat expectations, posting strong revenue and earnings growth, as well as bumping up its full-year 2017 guidance.
The company's management team fielded questions from analysts in a conference call following the earnings announcement. Here are five intriguing things Illumina's executives said in the third-quarter update that investors will want to know. (Quotes courtesy of S&P Global Market Intelligence.)
Image source: Getty Images.
Source: Fool.com
Novartis AG ADR Aktie
94,20 €
-0,84 %
Die Novartis AG ADR Aktie hat nicht genug Einschätzungen für ein klares Sentiment.
Das Community-Kursziel von 110 € für Novartis AG ADR deutet auf ein leicht positives Wachstumspotenzial gegenüber 94.2 € hin.
